MontVue Capital Management’s Oracle ORCL Stock Holding History

MontVue Capital Management’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-918	Closed	-$258K	–	67
2025 Q3	$258K	Hold	918	–	–	0.17%	58
2025 Q2	$201K	Buy	+918	New	+$148K	0.14%	64

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MontVue Capital Management's ORCL Position: Q4 2025 in Review

MontVue Capital Management sold out of Oracle (ORCL) in Q4 2025, closing a stake of 918 shares — an estimated $258K sold.

MontVue Capital Management first reported a position in ORCL in Q2 2025 and held it in 2 quarters. The position peaked at $258K in Q3 2025. 3,760 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

MontVue Capital Management reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
MontVue Capital Management sold 918 Oracle shares in Q4 2025, an estimated $258K.
MontVue Capital Management first reported a position in Oracle in Q2 2025 and held it in 2 quarters.
MontVue Capital Management's Oracle position peaked at $258K in Q3 2025.
3,760 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on MontVue Capital Management's 13F filing for Q4 2025, filed 27 Jan 2026.